Abingdon Health Plc (LON:ABDX – Get Free Report) shares hit a new 52-week low during mid-day trading on Tuesday . The company traded as low as GBX 5.68 ($0.07) and last traded at GBX 5.99 ($0.08), with a volume of 99893 shares traded. The stock had previously closed at GBX 6 ($0.08).
Abingdon Health Trading Down 0.2 %
The firm has a market cap of £11.59 million, a price-to-earnings ratio of -14.56 and a beta of 0.13. The firm’s 50-day moving average is GBX 6.88 and its 200-day moving average is GBX 7.60. The company has a current ratio of 1.95, a quick ratio of 1.96 and a debt-to-equity ratio of 46.64.
Abingdon Health (LON:ABDX – Get Free Report) last issued its quarterly earnings data on Monday, March 24th. The company reported GBX (0.53) (($0.01)) earnings per share (EPS) for the quarter. Abingdon Health had a negative net margin of 20.72% and a negative return on equity of 62.56%.
About Abingdon Health
Abingdon Health is a world leading contract developer and manufacturer (CDMO) of high-quality rapid tests across all industry sectors, including healthcare, infectious disease, animal health, environmental and self-testing. Abingdon is the partner of choice for a growing global customer base and takes projects from initial concept through to routine and large-scale manufacturing and regulatory approval.
Read More
- Five stocks we like better than Abingdon Health
- Quiet Period Expirations Explained
- Beware of BigBear.ai: Insiders Are Selling—Should You?
- Investing in Commodities: What Are They? How to Invest in Them
- CrowdStrike Stock is a Buy as Cyberthreat Environment Expands
- 3 Warren Buffett Stocks to Buy Now
- Congress! Who Traded What During the Tariff-Induced Meltdown
Receive News & Ratings for Abingdon Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Abingdon Health and related companies with MarketBeat.com's FREE daily email newsletter.
